Periscope Capital’s Psyence Biomedical Warrant PBMWW Stock Holding History

Periscope Capital’s Portfolio PBMWW Stock Details PBMWW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-200,000	Closed	-$3.38K	–	252
2025 Q1	$3.38K	Hold	200,000	–	–	﹤0.01%	195
2024 Q4	$2.88K	Sell	200,000 -25,000	-11%	-$333	﹤0.01%	185
2024 Q3	$2.83K	Hold	225,000	–	–	﹤0.01%	241
2024 Q2	$2.36K	Sell	225,000 -75,000	-25%	-$4.17K	﹤0.01%	309
2024 Q1	$21K	Buy	+300,000	New	+$18.7K	0.01%	294

Other funds holding PBMWW

HCI

Harraden Circle Investments New York $784M AUM 20.59% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return

Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return

SCM

Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Periscope Capital's PBMWW Position: Q2 2025 in Review

Periscope Capital sold out of Psyence Biomedical Warrant (PBMWW) in Q2 2025, closing a stake of 200,000 shares — an estimated $3.38K sold.

Periscope Capital first reported a position in PBMWW in Q1 2024 and held it in 5 quarters. The position peaked at $21K in Q1 2024. 23 funds tracked by Wall St. Rank hold PBMWW as of Q2 2025.

Periscope Capital reported no remaining Psyence Biomedical Warrant position as of Q2 2025 after selling out during the quarter.
Periscope Capital sold 200,000 Psyence Biomedical Warrant shares in Q2 2025, an estimated $3.38K.
Periscope Capital first reported a position in Psyence Biomedical Warrant in Q1 2024 and held it in 5 quarters.
Periscope Capital's Psyence Biomedical Warrant position peaked at $21K in Q1 2024.
23 funds tracked by Wall St. Rank held Psyence Biomedical Warrant as of Q2 2025.

Based on Periscope Capital's 13F filing for Q2 2025, filed 14 Aug 2025.